C4#Laboratories,#LLC Suite#B202
Dear
Valued
Colleague,
C4
Laboratories,
LLC
1930
S.
Alma
School
Rd
Suite
B202
Mesa,
AZ
85210
"Patient
protection
through
true
science"
Thank
you
for
selecting
C4
Laboratories.
Our
goal
at
C4
is
to
provide
reliable
data
that
is
interpreted
within
the
appropriate
physiological
context,
to
ultimately
empower
patients
to
use
cannabis
medicine
more
effectively.
The
data
within
this
report
are
the
result
of
various
analytical
methods
that
have
been
developed
by
the
team
of
scientists
at
C4
Laboratories.
For
the
characterization
and
quantification
of
21
terpene
compounds
and
residual
solvents
we
use
Head--Space
Gas
Chromatography
with
Flame
Ionization
Detection
(HS--GC--FID).
Additionally,
Ultra
High
Performance
Liquid
Chromatography
(UHPLC)
is
used
for
the
characterization
and
quantification
of
the
10
major
phytocannabinoids
found
in
cannabis.
All
data
are
collected
in
concert
with
proper
quality
assurance/quality
control
measures
(QA/QC),
including
the
use
of
intermittent
analytical
blanks,
sample
spikes,
and
commercial
standards.
As
an
additional
measure
of
quality
control,
we
provide
a
historical
reference
(when
available)
to
analytical
results
from
an
equivalent
strain
of
cannabis/cannabis
product
to
draw
comparison.
We
understand
that
within
an
individual
strain
that
results
may
vary
as
a
result
of
variances
in
sample
homogeniety,
analytical
InfomrmethoEdnolvogiryo,
cnromp
ceonndtaitilo,nLs,L
geCnetic
drift,
and/or
gene
flow
during
hybridization.
However,
such
a
6060 N. Central Expressway Suite 500
Dallasc, oTemxapsa7r5is2o06n
can
provide
valuable
insight
into
sample
integrity
and/or
the
phenotypic
identity
of
the
analyzed
sample. Phone: 915-694-7132
E-Mail: zac@;
Additionally,
we
have
interpreted
all
data
within
the
physiological
context
provided
to
us
by
the
growing
ruitt
Meander Rd, Gboradnyb
ourfy
p, eTeerx-a-rsev7i6e0w49ed
scientific
research
studies.
Key
factors
to
consider
when
determing
how
to
most
999-7931 appropriately
use
a
particular
strain
of
cannabis
include,
but
are
not
limited
to,
an
evaluation
of
the
possible
t@
cannabinoid/terpene
synergies
and
an
analysis
of
the
various
cannabinoid
ratios,
particular
the
CBD--A/THC--
A
and
CBG/CBN
ratios.
Mr. Pruitt,
Within this rIetp
iosr
itmyopuorwtiallnftin
tdoi
nntoetrper
tehtaattio
wnsheonf t
ahenawlyazteinrgq
ucaalnitnyadbaitsa
trheesruelt
i cnagnfr
eoxmistth
neatural
variablity
of
cannabinoid
and
ses of your wteellrwpeanteer
cpoenrfcoermnterdatbiyonTsT
wI Eitnhviniro
innmdievnidtaul aLla
pbloarnattso.r
i Cesa.nTnhaebisnaomidp
lceosnwceenretrations
in
cannabis
flower
have
been
rved ction
aAngdenpcryepfo(aEurePndAd)
a . tosB
iprnieecrfrlyem,aesdteeh
to dedicsottilooangllyya
wanpditphrqo
ruveaesndptiefbiccyat
t ttihooen
thUoefn
irtvoeodolatSt
milteaatesassn.d
EAnssv
e simurocin-hvm,o
etlahntetiale
lanalysis
of
multiple
samples
from
any
ounds was peprfloarnmte
odf
uinstinegreEstP
Ais
rmeectohmodm8e2n6d0eBd. .Additionally, the quantification of metal
es and water anions was performed using EPA methods 200.7 and 300A, respectively. All
minations were executed using EPA approved methods and the resulting data has
rgone a thorouTghharnevki
e ywoua
n adgaisind
efoerm
yeoduarc
ccounraftiedeanncdec
oinm
Cp4le
tLea.boratories.
We
strive
to
be
an
authority
on
cannabis
education,
u have any quteasrtgioentsedab
tohuetrathpeiewsa
atnerdq
puaatliiteyndt
a ptraoatencdt/oiornth.
eAlisnote,
r apsre
ata
rteiosnesarocfht
h laebdoartaat,ory,
we
hope
to
discover
novel
e do not hesitactaentnoacboinst
a ccotnusstiatut zeanct@ s
tinhfroorumgehn
v o.cuorm
efofor r9t1s5
w-6i9th4-
a71ca3d2.emic
research
programs
in
the
C4
Cannabinomics
Collaborative.
For
more
information
about
how
you
can
collaborate
with
our
research
team
please
visit
our
website
at
.
Zacariah
L.
Hildenbrand,
Ph.D. Chief
Scientific
Officer C4
Laboratories,
LLC
Zacariah L. Hildenbrand, Ph.D. Chief Technology Officer
PRODUCT
SUMMARY
ID: EC_DCBD1_121715
Analyte: Flower
Strain: DCBD1
Client: Errl
Cup
Date: 12/17/15
Microbial
Screen: PASS
Foreign
Material: PASS
Pesticide
Analysis: Not
performed
Residual
Solvents: Not
performed
Major
10
Cannabinoids:
23.78%
Total
available
THC:
8.28%
Total
THC
Isomers:
8.28% 9
+
8
THC
Total
available
CBD:
12.06%
Highest
Terpenes: Not
performed
Not
performed
Not
performed
Activated
THC: 0.000 (mg)
APPLICABLE
TO
MEDIBLES,
TINCTURES
AND
SALVES
Fresh
product
(CBG/CBN):
0.00
CBG/CBN
>
1.0
denotes
fresh
product,
CBG/CBN
<
1.0
denotes
high
CBN
strain
and/or
an
oxidized
product
Targeted
Use: Modulates
THC--induced
psychoactivity
(CBD),
anti--inflammatory
and
analgesic
(THC),
appetite
stimulant
(CBN),
antibacterial
and
antifungal
(CBC)
Potency
Profile CBDV
CBD--A
Value
(%) 0.00
13.75
Historical
(%)
Therapeutic
properties
#N/A #N/A
Not
detected.
See
therapeutic
properties
of
CBD
for
medicinal
value
upon
activation
through
decarboxylation
CBG
Not
detected.
0.00
#N/A
CBD
Not
detected.
0.00
#N/A
THCV CBN 9--THC
Not
detected.
0.00
#N/A
Appetite
stimulant
(Farrimond
et
al.,
2012),
analgesic
(Zygmunt
et
al.,
2002)
and
anti--tumorigenic
against
some
0.39
#N/A forms
of
lung
cancer
(BiFulco
et
al.,
2006)
Anti--inflammatory
and
analgesic
(Russo,
2011),
neuroprotectant
(Hampson
et
al.,
1999),
reduces
intraocular
pressure
associated
with
glaucoma,
spasticity
and
muscle
1.06
#N/A tension
(Pacher
et
al.,
2006)
8--THC
0.00
CBC
9--THC--A
Total
Available
THC Total
THC
Isomers Total
Available
CBD CBD/9--THC
ratio
CBG/CBN
ratio
0.35
8.23
8.28 8.28 12.06 1.457 0.00
#N/A
#N/A #N/A #N/A #N/A #N/A #N/A #N/A
Not
detected.
Antibacterial
and
antifungal
(ElSohly
et
al.,
1982),
anti-- inflammatory
(Izzo
et
al.,
2012;
Delong
et
al.,
2010),
antidepressant
(El--Alfy
et
al.,
2010;
Deyo
and
Musty,
2003),
and
stimulates
bone
and
nerve
growth
(Shingyo
and
Di
Marzo,
2013) See
therapeutic
properties
of
9--THC
for
medicinal
value
upon
activation
through
decarboxylation
General
Characteristics 9--THC--A
+
9--THC
(accounts
for
conversion
rate) 9--THC--A
+
9--THC
+
8--THC
(accounts
for
conversion
rate) CBD--A
+
CBD
(accounts
for
conversion
rate) CBD--dominant,
non--psychoactive CBG/CBN
>
1.0
denotes
fresh
product,
CBG/CBN
<
1.0
denotes
high
CBN
strain
and/or
an
oxidized
product
Major
10
Total
23.78
#N/A #N/A
Historical
measurements
based
on
analysis
of
equivalent
product
N/A
Blank
cells
denote
cannabinoid
concentrations
below
the
limit
of
detection
(0.01%)
#N/A
Terpene
Profile alpha--Pinene
Camphene beta--Pinene beta--Myrcene delta--3--Carene alpha--Terpinene p--Cymene
Value
(%) Historical
(%)
0.000
0.000
0.000
0.000 0.000 0.000 0.000
#N/A
#N/A
#N/A
#N/A #N/A #N/A #N/A
Not
detected. Not
detected. Not
detected. Not
detected. Not
detected. Not
detected.
Therapeutic
properties
d--Limonene
Ocimene gamma--Terpinene
Terpinolene
0.000
0.000 0.000 0.000
#N/A
#N/A #N/A #N/A
Not
detected.
Not
detected. Not
detected. Not
detected.
Linalool (--)--Isopulegol
Geraniol
0.000 0.000
0.000
#N/A #N/A
#N/A
Not
detected. Not
detected. Not
detected.
beta--Caryophyllene alpha--Humulene
0.000 0.000
#N/A #N/A
Not
detected. Not
detected.
Nerolidol Guaiol
(--)--alpha--Bisabolol
0.000 0.000 0.000
#N/A #N/A #N/A
Not
detected. Not
detected. Not
detected.
Eucalyptol (--)--Caryophyllene
oxide
Terpene
Total
0.000
0.000 0.000
#N/A
#N/A #N/A
Not
detected. Not
detected. #N/A
*
Based
on
historical
measurements
of
equivalent
strain/product Blank
cells
denote
terpene
concentrations
below
the
limit
of
detection
(0.001%)
Cannabinoid
Ratios CBD--A/9--THC--A
ratio
is
within
the
optimal
therapeutic
range
of
1--2
(Lemberger
et
al.,
1976;
Burnett,
2014) CBD--A/9--THC--A
ratio
is
above
1,
user
is
less
likely
to
experience
tachycardia
(increased
heart
rate)
and
difficulty
walking,
which
can
result
from
THC
ingestion
(Burnett,
2014) CBG/CBN
>
1.0
denotes
fresh
product
and
is
useful
for
the
treatment
of
gastrointestinal
abnormalities
(Borrelli
et
al.,
2013),
CBG/CBN
<
1.0
denotes
high
CBN
strain
and/or
an
oxidized
product
Cannabinoid/Terpene
Synergies
(Russo,
2011)
Additional
Observations Terpene
analysis
was
not
performed Residual
Solvents Not
performed Pesticides Not
performed
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
Related searches
- analysis laboratories inc
- laboratories near me
- blood test laboratories near me
- abbott laboratories products
- abbott laboratories similac
- water analysis laboratories near me
- water testing laboratories near me
- life science laboratories inc
- life laboratories inc
- florida laboratories inc
- aviation laboratories inc
- watson laboratories inc